Royce & Associates LP Trans Medics Group, Inc. Transaction History

Royce & Associates LP

$8.75 Billion
Q1 2025

A detailed history of Royce & Associates LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 297,200 shares of TMDX stock, worth $31.2 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

297,200

Previous 297,198 -0.0%

Holding current value

$31.2 Million

Previous $18.5 Million 7.91%

% of portfolio

0.23%

Previous 0.18%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	BUY	$56.73 - $79.42 $113 - $158	2 Added 0.0%	297,200 $20 Million
Q3 2024 Nov 06, 2024	SELL	$135.68 - $176.11 $542,720 - $704,440	-4,000 Reduced 1.33%	297,198 $46.7 Million
Q2 2024 Aug 13, 2024	SELL	$72.62 - $150.62 $1.02 Million - $2.11 Million	-14,000 Reduced 4.44%	301,198 $45.4 Million
Q1 2024 May 13, 2024	SELL	$70.86 - $89.93 $2.59 Million - $3.28 Million	-36,500 Reduced 10.38%	315,198 $23.3 Million
Q4 2023 Feb 12, 2024	BUY	$36.74 - $81.08 $7.72 Million - $17 Million	210,000 Added 148.2%	351,698 $27.8 Million
Q3 2023 Nov 09, 2023	BUY	$53.47 - $96.07 $224,467 - $403,301	4,198 Added 3.05%	141,698 $7.76 Million
Q2 2023 Aug 07, 2023	SELL	$66.23 - $88.73 $1.46 Million - $1.95 Million	-22,000 Reduced 13.79%	137,500 $11.5 Million
Q1 2023 May 04, 2023	SELL	$53.63 - $82.33 $1.74 Million - $2.68 Million	-32,500 Reduced 16.93%	159,500 $12.1 Million
Q4 2022 May 23, 2023	BUY	$39.08 - $64.29 $1.27 Million - $2.09 Million	32,500 Added 20.38%	192,000 $11.9 Million
Q4 2022 Feb 13, 2023	BUY	$39.08 - $64.29 $1.56 Million - $2.57 Million	40,000 Added 26.32%	192,000 $11.9 Million
Q3 2022 Nov 03, 2022	BUY	$31.56 - $55.75 $315,600 - $557,500	10,000 Added 7.04%	152,000 $6.34 Million
Q2 2022 Aug 04, 2022	BUY	$20.56 - $32.15 $1.13 Million - $1.77 Million	55,000 Added 63.22%	142,000 $4.47 Million
Q1 2022 May 05, 2022	BUY	$12.58 - $26.94 $327,080 - $700,440	26,000 Added 42.62%	87,000 $2.34 Million
Q4 2021 Feb 07, 2022	BUY	$19.16 - $32.68 $1.17 Million - $1.99 Million	61,000 New	61,000 $1.17 Million
Q4 2020 Feb 08, 2021	SELL	$11.91 - $19.9 $488,310 - $815,899	-41,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$13.78 - $18.84 $564,980 - $772,440	41,000 New	41,000 $565,000

Others Institutions Holding TMDX

# of Institutions

354

Shares Held

32.1M

Call Options Held

852K

Put Options Held

690K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $3.34B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Trans Medics Group, Inc. Transaction History